Platelet-activating factor induces TLR4 expression in intestinal epithelial cells: Implication for the pathogenesis of necrotizing enterocolitis

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Soliman, Antoine ^a   Michelsen, Kathrin S ^a   Karahashi, Hisae ^a   Lu, Jing ^b,c   Meng, Fan Jing ^c   Qu, Xiaowu ^c   Crother, Timothy R ^a   Rabizadeh, Shervin ^a   Chen, Shuang ^a   Caplan, Michael S ^b,c   Arditi, Moshe ^a   Jilling, Tamas ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c EVANSTON NORTHWESTERN HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; STAT3 PROTEIN; THROMBOCYTE ACTIVATING FACTOR; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; EX VIVO STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; MOUSE; NECROTIZING ENTEROCOLITIS; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL LINE; GENETICS; INTESTINE MUCOSA; METABOLISM; PHYSIOLOGY;

RATTUS;

ANIMALS; CELL LINE; ENTEROCOLITIS, NECROTIZING; HUMANS; INTESTINAL MUCOSA; PLATELET ACTIVATING FACTOR; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 78149455161     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015044     Document Type: Article

References (53)

1. Caplan MS, MacKendrick W (1994) Inflammatory mediators and intestinal injury. Clin Perinatol 21: 235-246.
2. Edelson MB, Bagwell CE, Rozycki HJ (1999) Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 103: 766-771.
3. Kliegman RM (1990) Models of the pathogenesis of necrotizing enterocolitis. J Pediatr 117: S2-5.
4. Hsueh W, Caplan MS, Qu XW, Tan XD, De Plaen IG, et al. (2003) Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 6: 6-23.
5. Caplan MS, Hedlund E, Adler L, Lickerman M, Hsueh W (1997) The plateletactivating factor receptor antagonist WEB 2170 prevents neonatal necrotizing enterocolitis in rats. J Pediatr Gastroenterol Nutr 24: 296-301.
6. Caplan MS, Hsueh W (1990) Necrotizing enterocolitis: role of platelet activating factor, endotoxin, and tumor necrosis factor. J Pediatr 117: S47-51.
7. Caplan MS, Lickerman M, Adler L, Dietsch GN, Yu A (1997) The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis. Pediatr Res 42: 779-783.
8. Caplan MS, Sun XM, Hsueh W (1990) Hypoxia causes ischemic bowel necrosis in rats: the role of platelet-activating factor (PAF-acether). Gastroenterology 99: 979-986.
9. Gonzalez-Crussi F, Hsueh W (1983) Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin. Am J Pathol 112: 127-135.
10. Hsueh W, Gonzalez-Crussi F, Arroyave JL (1987) Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. Faseb J 1: 403-405.
11. Hsueh W, Gonzalez-Crussi F, Arroyave JL (1986) Platelet-activating factorinduced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis. Am J Pathol 122: 231-239.
12. Sun XM, Hsueh W (1988) Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. J Clin Invest 81: 1328-1331.
13. Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM (2002) The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med 30: S294-301.
14. Benveniste J (1988) Paf-acether, an ether phospho-lipid with biological activity. Prog Clin Biol Res 282: 73-85.
15. Venable ME, Zimmerman GA, McIntyre TM, Prescott SM (1993) Plateletactivating factor: a phospholipid autacoid with diverse actions. J Lipid Res 34: 691-702.
16. Jilling T, Simon D, Lu J, Meng FJ, Li D, et al. (2006) The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J Immunol 177: 3273-3282.
17. Barlow B, Santulli TV, Heird WC, Pitt J, Blanc WA, et al. (1974) An experimental study of acute neonatal enterocolitis-the importance of breast milk. J Pediatr Surg 9: 587-595.
18. Akira S (2003) Toll-like receptor signaling. J Biol Chem 278: 38105-38108.
19. Leaphart CL, Cavallo J, Gribar SC, Cetin S, Li J, et al. (2007) A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. Journal of immunology (Baltimore, Md 179: 4808-4820.
20. Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, et al. (2001) Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 167: 1609-1616.
21. Melmed G, Thomas LS, Lee N, Tesfay SY, Lukasek K, et al. (2003) Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2- dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol 170: 1406-1415.
22. Naik S, Kelly EJ, Meijer L, Pettersson S, Sanderson IR (2001) Absence of Tolllike receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium. J Pediatr Gastroenterol Nutr 32: 449-453.
23. McIntire FC, Sievert HW, Barlow GH, Finley RA, Lee AY (1967) Chemical, physical, biological properties of a lipopolysaccharide from Escherichia coli K-235. Biochemistry 6: 2363-2372.
24. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ (2000) Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 165: 618-622.
25. Qureshi N, Takayama K, Sievert TR, Manthey CL, Vogel SN, et al. (1995) Novel method for the purification and characterization of lipopolysaccharide from Escherichia coli D31m3. Prog Clin Biol Res 392: 151-160.
26. Hajjar AM, O'Mahony DS, Ozinsky A, Underhill DM, Aderem A, et al. (2001) Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J Immunol 166: 15-19.
27. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, et al. (1999) Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 163: 3920-3927.
28. Augeron C, Laboisse CL (1984) Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res 44: 3961-3969.
29. Rehli M, Poltorak A, Schwarzfischer L, Krause SW, Andreesen R, et al. (2000) PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene. J Biol Chem 275: 9773-9781.
30. Zhang FX, Kirschning CJ, Mancinelli R, Xu XP, Jin Y, et al. (1999) Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem 274: 7611-7614.
31. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, et al. (2000) Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 164: 966-972.
32. Lukashova V, Asselin C, Krolewski JJ, Rola-Pleszczynski M, Stankova J (2001) G-protein-independent activation of Tyk2 by the platelet-activating factor receptor. J Biol Chem 276: 24113-24121.
33. Heon Seo K, Ko HM, Kim HA, Choi JH, Jun Park S, et al. (2006) Plateletactivating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation. Cancer Research 66: 4681-4686.
34. Abreu MT, Arnold ET, Thomas LS, Gonsky R, Zhou Y, et al. (2002) TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem 277: 20431-20437.
35. Ishii S, Nagase T, Tashiro F, Ikuta K, Sato S, et al. (1997) Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO Journal 16: 133-142.
36. Stafforini DM, Numao T, Tsodikov A, Vaitkus D, Fukuda T, et al. (1999) Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma. Journal of Clinical Investigation 103: 989-997.
37. Ackerman Z, Karmeli F, Ligumsky M, Rachmilewitz D (1990) Enhanced gastric and duodenal platelet-activating factor and leukotriene generation in duodenal ulcer patients. Scandinavian Journal of Gastroenterology 25: 925-934.
38. Kald B, Smedh K, Olaison G, Sjodahl R, Tagesson C (1996) Platelet-activating factor acetylhydrolase activity in intestinal mucosa and plasma of patients with Crohn's disease. Digestion 57: 472-477.
39. Eliakim R, Karmeli F, Razin E, Rachmilewitz D (1988) Role of plateletactivating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. Gastroenterology 95: 1167-1172.
40. Wang H, Tan X, Chang H, Gonzalez-Crussi F, Remick DG, et al. (1997) Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor. Biochem J 322(Pt 2): 603-608.
41. Jilling T, Lu J, Jackson M, Caplan MS (2004) Intestinal epithelial apoptosis initiates gross bowel necrosis in an experimental rat model of neonatal necrotizing enterocolitis. Pediatr Res 55: 622-629.
42. Lu J, Caplan MS, Saraf AP, Li D, Adler L, et al. (2004) Platelet-activating factorinduced apoptosis is blocked by Bcl-2 in rat intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 286: G340-350.
43. Suzuki M, Hisamatsu T, Podolsky DK (2003) Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex. Infect Immun 71: 3503-3511.
44. Cario E, Podolsky DK (2000) Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68: 7010-7017.
45. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241.
46. Fukata M, Michelsen KS, Eri R, Thomas LS, Hu B, et al. (2005) Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol 288: G1055-1065.
47. Fusunyan RD, Nanthakumar NN, Baldeon ME, Walker WA (2001) Evidence for an innate immune response in the immature human intestine: toll-like receptors on fetal enterocytes. Pediatr Res 49: 589-593.
48. Amer MD, Hedlund E, Rochester J, Caplan MS (2004) Platelet-activating factor concentration in the stool of human newborns: effects of enteral feeding and neonatal necrotizing enterocolitis. Biol Neonate 85: 159-166.
49. Deo DD, Axelrad TW, Robert EG, Marcheselli V, Bazan NG, et al. (2002) Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. J Biol Chem 277: 21237-21245.
50. Deo DD, Bazan NG, Hunt JD (2004) Activation of platelet-activating factor receptor-coupled G alpha q leads to stimulation of Src and focal adhesion kinase via two separate pathways in human umbilical vein endothelial cells. J Biol Chem 279: 3497-3508.
51. Panopoulos AD, Bartos D, Zhang L, Watowich SS (2002) Control of myeloidspecific integrin alpha Mbeta 2 (CD11b/CD18) expression by cytokines is regulated by Stat3-dependent activation of PU.1. The Journal of biological chemistry 277: 19001-19007.
52. De Plaen IG, Tan XD, Chang H, Wang L, Remick DG, et al. (2000) Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet-activating factor and tumour necrosis factor. British Journal of Pharmacology 129: 307-314.
53. Seo KH, Lee HS, Jung B, Ko HM, Choi JH, et al. (2004) Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation. Cancer Research 64: 6482-6488.